SAO PAULO, June 5 (Xinhua) -- A Brazilian expert has lauded the decision by the World Health Organization (WHO) to approve China's CoronaVac COVID-19 vaccine for emergency use.
In an interview with Xinhua, Ricardo Palacios, the director of clinical research at the Butantan Institute in Brazil, said, "The WHO's approval of China's CoronaVac is of great significance. It could allow greater access of the vaccines for countries that are part of the COVAX system."
The WHO recently validated Sinovac's CoronaVac vaccine, assuring the world that it meets international standards for safety, efficacy, and manufacturing.
Palacios also hailed China's contribution of making its vaccines a global public good. He said, "This shows China's generosity in sharing this limited resource to help other countries control the epidemic, including countries in Latin America, which is one of the most affected regions in the world. This generosity is really impressive."
Produced by Xinhua Global Service